Abstract
Abstract1. Ten Rh-negative sensitized pregnant women were treated with Rh hapten in doses of 100 to 600 mg. weekly for periods varying from seven to twenty-eight weeks antepartum.2. Three patients with heterozygous husbands delivered Rh-negative infants. Maternal antibody titers were unaffected by hapten therapy.3. Three patients delivered Rh-positive infants displaying varying degrees of erythroblastosis fetalis.4. The pregnancies of 4 patients terminated with fetal deaths in utero despite hapten therapy.5. There does not seem to be any evidence that Rh hapten in the doses and manner employed altered the course or outcome of any of the 10 pregnancies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
